辛伐他汀联合银杏达莫治疗不稳定型心绞痛的临床研究

目的：探讨在不稳定型心绞痛治疗中使用辛伐他汀联合银杏达莫的临床疗效。方法：2005年6月～2009年6月本院确诊为不稳定型心绞痛的患者68例，将其随机分成对照组和治疗组，每组34例。对照组施行常规的治疗，治疗组在常规治疗的基础上，增加辛伐他汀和银杏达莫。结果：对照组和治疗组患者在治疗早期不稳定型心绞痛的发作均得到了有效控制，但总体来说治疗组的有效率要高于对照组，在从远期效果来说，对照组发展成复合性心血管的比例高于治疗组，无效的比例也高于治疗组。结论：在不稳定型心绞痛治疗中使用辛伐他汀联合银杏达莫有显著的效果．值得临床推广席用。

Clinical study of combined simvastatin and ginkgodipyidamolum in treatment of unstable angina

Objective： To study the clinical efficacy of combined simvastatin and ginkgodipyidamolum in the treatment of unstable angina. Methods： 68 patients diagnosed with unstable angina in our hospital from June 2005 to June 2009 were selected and randomly divided into the control group and the treatment groups of 34 patients respectively. The control group received conventional treatment while the treatment group received simvastatin and ginkgodipyidamolum on the basis of conventional treatment. Results： Both groups were effective in the treatment of early unstable angina, but the overall ef- fective rate of the treatment group was higher than that of the control group. As for the long-term efficacy, the proportion of developing into compound cardiovascular disease of the control group was higher than that of the treatment group and so did the ineffective proportion. Conclusion： Combined simvastatin and ginkgodipyidamolum has significant efficacy in the treatment of unstable angina, thereby worthy of clinical promotion and application.